SVV · Savers Value Village, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-08-11 | Walsh Mark T. |
Director, CEO & Director |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The December 9, 2020 stock option grant vested in substantially equal annual installments over five years starting December 9, 2021 and was fully vested on December 9, 2025. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
50,000 |
| 2026-08-11 | Walsh Mark T. |
Director, CEO & Director |
Convert↑
|
Common Stock
|
42,059 |
| 2026-08-11 | Walsh Mark T. |
Director, CEO & Director |
Convert↑
|
Common Stock
|
50,000 |
| 2026-08-11 | Walsh Mark T. |
Director, CEO & Director |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The October 7, 2019 stock option grant vested in substantially equal annual installments over five years starting October 7, 2020, and was fully vested on October 7, 2024. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
42,059 |
| 2026-08-11 | Walsh Mark T. |
Director, CEO & Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $11.72 to $12.15. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
Common Stock
|
92,059 |
| 2026-08-10 | Walsh Mark T. |
Director, CEO & Director |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The December 9, 2020 stock option grant vested in substantially equal annual installments over five years starting December 9, 2021 and was fully vested on December 9, 2025. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
50,000 |
| 2026-08-10 | Walsh Mark T. |
Director, CEO & Director |
Convert↑
|
Common Stock
|
50,000 |
| 2026-08-10 | Walsh Mark T. |
Director, CEO & Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $11.74 to $12.41. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
Common Stock
|
100,000 |
| 2026-08-10 | Walsh Mark T. |
Director, CEO & Director |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The October 7, 2019 stock option grant vested in substantially equal annual installments over five years starting October 7, 2020, and was fully vested on October 7, 2024. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
50,000 |
| 2026-08-10 | Walsh Mark T. |
Director, CEO & Director |
Convert↑
|
Common Stock
|
50,000 |
| 2026-08-07 | Medway Richard A. |
General Counsel |
Convert↑
|
Common Stock
|
23,344 |
| 2026-08-07 | Medway Richard A. |
General Counsel |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024. The total outstanding excludes the portion of the original option grant that was solely time-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
5,000 |
| 2026-08-07 | Walsh Mark T. |
Director, CEO & Director |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The October 7, 2019 stock option grant vested in substantially equal annual installments over five years starting October 7, 2020, and was fully vested on October 7, 2024. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
50,000 |
| 2026-08-07 | Geisser Melinda L. |
Chief People Services Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026. |
Common Stock
|
20,000 |
| 2026-08-07 | Geisser Melinda L. |
Chief People Services Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026. |
Common Stock
|
15,000 |
| 2026-08-07 | Walsh Mark T. |
Director, CEO & Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $11.05 to $12.05. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
Common Stock
|
13,036 |
| 2026-08-07 | Walsh Mark T. |
Director, CEO & Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $11.05 to $12.04. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
Common Stock
|
13,062 |
| 2026-08-07 | Medway Richard A. |
General Counsel |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026. |
Common Stock
|
15,000 |
| 2026-08-07 | Geisser Melinda L. |
Chief People Services Officer |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
50,000 |
| 2026-08-07 | Walsh Mark T. |
Director, CEO & Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $12.07 to $12.63. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
Common Stock
|
36,964 |
| 2026-08-07 | Medway Richard A. |
General Counsel |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026. |
Common Stock
|
15,000 |
| 2026-08-07 | Medway Richard A. |
General Counsel |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
23,344 |
| 2026-08-07 | Walsh Mark T. |
Director, CEO & Director |
Convert↑
|
Common Stock
|
50,000 |
| 2026-08-07 | Maher Michael W |
CFO & Treasurer |
Convert↑
|
Common Stock
|
44,742 |
| 2026-08-07 | Walsh Mark T. |
Director, CEO & Director |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The December 9, 2020 stock option grant vested in substantially equal annual installments over five years starting December 9, 2021 and was fully vested on December 9, 2025. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
50,000 |
| 2026-08-07 | Maher Michael W |
CFO & Treasurer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 2, 2026. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $12.00 to $12.65. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
Common Stock
|
44,742 |
| 2026-08-07 | Medway Richard A. |
General Counsel |
Convert↑
|
Common Stock
|
16,656 |
| 2026-08-07 | Walsh Mark T. |
Director, CEO & Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $12.06 to $12.67. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
Common Stock
|
36,938 |
| 2026-08-07 | Maher Michael W |
CFO & Treasurer |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting conditions. Reflects an award of non-qualified stock options pursuant to the Savers Value Village Omnibus Incentive Compensation Plan that are scheduled to vest in approximately one-third increments on March 12, 2026, March 12, 2027 and March 12, 2028. |
Stock Options (Right to Purchase)
|
44,742 |
| 2026-08-07 | Geisser Melinda L. |
Chief People Services Officer |
Convert↑
|
Common Stock
|
50,000 |
| 2026-08-07 | Medway Richard A. |
General Counsel |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The December 9, 2020 stock option grant vested in substantially equal annual installments over five years starting December 9, 2021 and was fully vested on December 9, 2025. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
16,656 |
| 2026-08-07 | Geisser Melinda L. |
Chief People Services Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026. |
Common Stock
|
15,000 |
| 2026-08-07 | Maher Michael W |
CFO & Treasurer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 2, 2026. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $12.00 to $12.61. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
Common Stock
|
5,000 |
| 2026-08-07 | Medway Richard A. |
General Counsel |
Convert↑
|
Common Stock
|
5,000 |
| 2026-08-07 | Walsh Mark T. |
Director, CEO & Director |
Convert↑
|
Common Stock
|
50,000 |
| 2026-08-07 | Medway Richard A. |
General Counsel |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026. |
Common Stock
|
15,000 |
| 2026-08-06 | Walsh Mark T. |
Director, CEO & Director |
Convert↑
|
Common Stock
|
50,000 |
| 2026-08-06 | Walsh Mark T. |
Director, CEO & Director |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The December 9, 2020 stock option grant vested in substantially equal annual installments over five years starting December 9, 2021 and was fully vested on December 9, 2025. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
50,000 |
| 2026-08-06 | Walsh Mark T. |
Director, CEO & Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $10.3850 to $11.04. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
Common Stock
|
50,000 |
| 2026-08-06 | Walsh Mark T. |
Director, CEO & Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $10.50 to $11.04. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
Common Stock
|
50,000 |
| 2026-08-06 | Walsh Mark T. |
Director, CEO & Director |
Convert↑
|
Common Stock
|
50,000 |
| 2026-08-06 | Walsh Mark T. |
Director, CEO & Director |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The October 7, 2019 stock option grant vested in substantially equal annual installments over five years starting October 7, 2020, and was fully vested on October 7, 2024. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
50,000 |
| 2026-08-05 | Walsh Mark T. |
Director, CEO & Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $11.00 to $11.09. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
Common Stock
|
7,941 |
| 2026-08-05 | Medway Richard A. |
General Counsel |
Convert↑
|
Common Stock
|
10,000 |
| 2026-08-05 | Geisser Melinda L. |
Chief People Services Officer |
Convert↑
|
Common Stock
|
15,000 |
| 2026-08-05 | Walsh Mark T. |
Director, CEO & Director |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The October 7, 2019 stock option grant vested in substantially equal annual installments over five years starting October 7, 2020, and was fully vested on October 7, 2024. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
7,941 |
| 2026-08-05 | Walsh Mark T. |
Director, CEO & Director |
Convert↑
|
Common Stock
|
7,941 |
| 2026-08-05 | Medway Richard A. |
General Counsel |
Convert↓
Filing footnotes — Stock Options (Right to Purchase) (Direct)
Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
Stock Options (Right to Purchase)
|
10,000 |
| 2026-08-05 | Medway Richard A. |
General Counsel |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026. |
Common Stock
|
10,000 |
| 2026-08-05 | Geisser Melinda L. |
Chief People Services Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026. |
Common Stock
|
15,000 |